ALPS ADVISORS INC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 165 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$183,155
-34.2%
42,397
+0.4%
0.00%0.0%
Q2 2023$278,256
+9.5%
42,224
+12.9%
0.00%0.0%
Q1 2023$254,014
-10.7%
37,410
-2.8%
0.00%
-33.3%
Q4 2022$284,389
-6.5%
38,483
+24.9%
0.00%0.0%
Q3 2022$304,000
-16.7%
30,808
-8.1%
0.00%
-25.0%
Q2 2022$365,000
-43.8%
33,512
-41.7%
0.00%
-42.9%
Q1 2022$650,000
-35.8%
57,455
-10.9%
0.01%
-36.4%
Q4 2021$1,012,000
-13.4%
64,469
-5.5%
0.01%0.0%
Q3 2021$1,169,000
-25.7%
68,193
-6.8%
0.01%
-21.4%
Q2 2021$1,574,000
+5.6%
73,185
-26.3%
0.01%
-6.7%
Q1 2021$1,491,000
-10.0%
99,290
-21.2%
0.02%
-21.1%
Q4 2020$1,656,000
+511.1%
125,994
+349.3%
0.02%
+375.0%
Q3 2020$271,000
-35.6%
28,040
+9.2%
0.00%
+33.3%
Q4 2019$421,000
+18.3%
25,666
-4.2%
0.00%0.0%
Q3 2019$356,000
+24.5%
26,782
+32.0%
0.00%
+50.0%
Q2 2019$286,000
-27.2%
20,284
-5.0%
0.00%
-33.3%
Q1 2019$393,000
+16.3%
21,354
-41.2%
0.00%0.0%
Q4 2015$338,000
-91.8%
36,3440.0%0.00%
-25.0%
Q3 2015$4,100,00036,3440.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders